News & Analysis on Clinical Trial Services & Contract Research And Development
A new study condemns the high prevalence of ghost writing in pharmaceutical company-sponsored clinical trials and calls for the controversial practice to be culled in order to improve transparency.
US-based Blue Mountain has launched an integrated, comprehensive software package to help life sciences companies manage their assets, cutting out the need for individual software.
A new player has entered the pharma formulation development services arena, offering technologies used in the food industry to improve drug palatability.
Covance was nothing but optimistic about the future of contract research organisations (CROs) during a JPMorgan healthcare conference held last week, despite a slowdown in R&D spending over the past year.
Researchers in Belgium have succeeded in using plant seeds to produce high yields of proteins that bear a strong resemblance to human antibodies, thus bringing the possibility of using plant systems as an inexpensive alternative to current drug...
A multi-million dollar US manufacturing contract for Acambis hinges on whether or not the firm can satisfy the Food and Drug Administration (FDA) that its investigational smallpox vaccine should be approved.
More cattle-derived materials used in the production of medical products are due to be banned in the US Food and Drug Administration's (FDA) latest steps to protect against mad cow disease.
Drug giants Novartis and GlaxoSmithKline (GSK) have been awarded contracts with the US government to develop adjuvant technology for pandemic influenza, to potentially increase the number of doses to be distributed among US citizens.
Two companies have gone a step further to capture a bigger chunk of the budding eClinical market by offering a new integrated solution for pharma companies who continue to move away from paper toward electronic reporting in clinical trials.